Podcasts about DDT

Dr. Andrew Kaufman appears on Outer Limits of Inner Truth to discuss terrain theory, the mind body connection, and personal health autonomy. He begins with the period when fear dominated public life, sharing his observations about how institutions leaned on it to override individual rights, then moves into his central medical argument, that the body operates on its internal terrain and inner state far more than on outside invaders. The strongest and most substantive stretch of the interview is the mind body material, where Kaufman draws on the adverse childhood experiences research linking early trauma to chronic disease in adulthood, explains the nocebo effect using the example of patients who developed chemotherapy side effects after receiving only a saline solution, and argues that unresolved emotional conflict can physically obstruct the body's ability to heal itself. The second half turns to the everyday inputs Kaufman believes shape long term health. He makes a detailed case for real, local, seasonal, minimally processed food, reasoning both from the composition of the human body and from medical anthropology describing populations before colonization who lived largely free of chronic disease. He raises concerns about seed oils, the role of chronic stress and cortisol, and what he calls obesogens, the persistent environmental toxins and forever chemicals such as DDT and PCBs that researchers have found stored in human fat for decades. Kaufman also shares his perspective on conventional medicine and alternative approaches to treatment, and frames the entire conversation around the idea of becoming your own doctor and refusing to outsource your judgment. He closes by pointing listeners to the free resources on his website, including his detox protocol and his masterclass on handling medical situations at home. Website: https://medauthentica.com/ ----- Dr. Andy Kaufman, a "recovering physician," transitioned from a prestigious mainstream medical career to challenge conventional paradigms. Trained in allopathic medicine, his journey of questioning traditional principles led him to become a dynamic educator and speaker. Dr. Andy shares insights on medicine, viruses, and natural healing, while exploring interconnected fields like economics, law, and science, offering a holistic perspective that inspires critical thinking. With a Bachelor of Science in Biology from MIT, an MD from the University of South Carolina, and a psychiatric residency at Duke University, Dr. Andy has held academic leadership roles, contributed to research, and patented a medical device. Now, he dedicates himself to researching and delivering trustworthy products and protocols, empowering health-seekers to achieve optimal wellness. Follow Dr. Andy Kaufman on Medicamentum Authentica (YouTube, Instagram, Rumble) to gain knowledge and take charge of your health journey. Keywords: Andrew Kaufman, terrain theory, germ theory, mind body connection, ACE study, childhood trauma, nocebo effect, ancestral diet, seed oils, cortisol and stress, obesogens, environmental toxins, medical freedom, health autonomy, becoming your own doctor, bodily autonomy

John and Eric (fka Snazzy??) are back for another super packed episode of Wrestling Omakase! They start things off with some discussion of VOW's latest edition of the 30 Under 30 project- who they voted for that got lost in the honorable mentions, then as 30-16 dropped right when they started recording they go through that list as well. Plus, lots of discussion on young wrestlers and how different places do (or don't) develop them in general! Then it's on to a major topic from last week, as they talk the major news of NJPW's sale from Bushiroad to TV Asahi & Cyberagent, including a lot of things they think people are getting wrong about this topic so far.Then of course it's on to our show reviews, starting out with a STARDOM Korakuen show from 5/26 packed with major news: of course, Utami Hayashishita's sudden return to the company being the big one, but also a major title change on top. They break it all down as well as the sudden burst of unit movement from this past weekend as well. Then it's on to NJPW BOSJ Nights 8-10 (5/27, 5/29 & 5/30) which were kind of the dog days of the tournament, though there were still a couple highlights (and some real lowlights as well).Afterward they talk a trio of shows that all took place on May 31st, starting with the King of DDT finals from Korakuen Hall. They break down a somewhat surprising winner, whether or not this was a mistake, if DDT's young talent is being pushed fast enough, "vibes" and more. Then it's over to Marvelous to talk their latest Shin Kiba 1st Ring show, featuring some notable foreign talent, Chigusa Nagayo's divisive commentary (Nicole made a run in for this part- she is not a fan!), and what's coming up next for them. Finally, it's back to the land of Ice Ribbon to discuss their show from Yokohama that John was particularly invested in the result of, as their favorite wrestler in the promotion tries to earn a title shot on a show they're going to next month! Also somewhere in here we rank the Omakase co-hosts by who would beat who in a FIGHT, so definitely don't miss that!Joshi-ing Around podcast: https://redcircle.com/shows/1309343e-3781-4750-9209-4efbc9976ab6Social Suplex newsletter: https://www.socialsuplex.com/newsletter/Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Every now and then, a conservation opportunity comes along that you can't pass up. The Western NY Land Conservancy (WNYLC) is currently in a race to permanently protect the Bear Lake Preserve, 311 acres of undeveloped shoreline, mature forest, and an array of critical wetland habitats linked to the Lake.To break down what makes this property so special, the guys hit the trail with WNYLC Stewardship Director Josh Balisteri. He gives them a tour of the property, discussing the history and ecology of Bear Lake, the historical and global crisis of wetland loss, and why we need to start viewing the Great Lakes ecosystem through the lens of crucial "inland coasts."Head over to wnylc.org/bearlake to check out maps of the new preserve and support their work!This episode was recorded at Bear Lake in Stockton, NY (and Pomfret, NY) on May 18, 2026.Episode Notes and LinksLucy and Bear Lake:During the episode, Bill boldly threw out a bit of local lore suggesting that WNY's favorite daughter, Lucille Ball, once stayed at a cottage on Bear Lake. He diligently searched online for any evidence that this was true, but came up empty. Lucy did grow up on the shores of nearby Chautauqua Lake in Celoron and spent many summers during the peak of her popularity escaping to Chenango Lake in eastern NY, but there is no official record of her hiding out at Bear Lake. Sorting Out Our Flight Paths: Later in the conversation, Bill referenced Darryl McGrath's excellent book Flight Paths: A Field Journal of Hope, Heartbreak, and Miracles with New York's Bird People and misidentified Hemlock Lake as one of the state's first eagle hacking (establishment) sites. While Bill was correct in remembering that Hemlock Lake was mentioned in the book, he was confused about the context. In reality, Hemlock Lake played a far more poignant role: it was the home of the very last known native nesting pair of bald eagles in New York State. By the late 1970s, chemical contamination from DDT had devastated the population, and that lonely Hemlock Lake pair was all that remained of our national bird in the entire state. (The pioneering hacking program Bill was thinking of launched nearby at the Montezuma National Wildlife Refuge).Why the South Shore of Bear Lake Stayed Wild: A major piece of that puzzle comes down to local history: from the 1920s through the 1970s, the land was home to a vibrant YMCA camp, and local authors Bob and Anne Deming (who Josh mentioned as key people in aiding the effort to save Bear Lake) published a book mapping out the camp's history. Originally inspired by a single chapter in their debut book, A History of Bear Lake (recently updated and re-released), they dove deeper into the archives to publish Camp in the Woods, a collection of photos and first-hand accounts from nearly 500 former campers and staff members. Find their books on Amazon: Bob and Anne Deming's Author & Book PageRead more about the project: New Book Recounts Stories from Y Camp in the WoodsSpecial thanks to Andrew Gaerte, the Western New York Land Conservancy's Director of Development and Communications, for sharing this history with us!Find out more about the Western NY Land Conservancy, including the Bear Lake Project and their Western NY Wildway.Sponsors and Ways to Support UsThank you to Always Wandering Art (Website and Etsy Shop) for providing the artwork for many of our episodes.Support us on Patreon.Works CitedPeterjohn, W.T. and Correll, D.L., 1984. Nutrient dynamics in an agricultural watershed: the role of a riparian forest. Ecology, 65(5), pp.1466-1475.Radomski, P. and Goeman, T.J., 2001. Consequences of human lakeshore development on emergent and floating-leaf vegetation abundance. North American Journal of Fisheries Management, 21(1), pp.46-61.Schindler, D.E., Geib, S.I. and Williams, M.R., 2000. Patterns of fish growth along a gradient of shoreline development. Nature, 407(6801), pp.202-205.This episode's photo is from the WNYLC's Bear Lake Project page!

En dag får den amerikanska biologen Rachel Carson ett brev från en vän som berättar att det ligger fullt med döda fåglar i trädgården. Marken har besprutats med bekämpningsmedlet DDT. Kan det finnas ett samband? Med boken "Tyst vår", utgiven 1962, visar Rachel Carson att svaret är ja. Bekämpningsmedel skadar inte bara insekter utan även andra djur och människor. Boken förändrar lagstiftningen i USA och blir startskottet till den moderna miljörörelsen. Men Rachel Carson får också svidande kritik från kemiindustrin. Programmet är en bearbetad version från 2018.

00:00 Привет! Пятая весна войны 02:38 Новая песня DDT 11:20 Сансара и «Всем девчонкам-заключенным» 19:22 Лигалайз и Руслан Белый 26:20 Мария Дубровина — новое имя и лучший дебют весны 33:19 Новый Mujuice 38:50 Миктлан — загробное царство и песня про ПТСР 43:25 Новый мини-альбом «Бумбокс» 50:38 ADÉLA — словацкая песня про КГБ «Первый отдел» в соцсетях:⁠поддержать⁠ «Первый отдел»⁠телеграм⁠⁠инстаграм⁠⁠твиттер⁠⁠ютубАнна Виленская в соцсетях:инстаграмютуб

Not much happened in this week, but we're here to talk SENJO, DDT, and NOAH!

Tom interviews Bernie Lewin about his 2017 book Searching for the Catastrophe Signal and his path from local environmentalism to blogging and writing for the Global Warming Policy Foundation. Lewin argues postwar “big science,” shifting religion's role in policy, and media narratives helped drive recurring environmental scares: DDT, ozone depletion tied to supersonic transport and CFCs, then 1970s global cooling amid energy crises. He claims funding incentives encouraged extreme atmospheric claims, and that policy often diverged from scientific uncertainty. The discussion covers the 1988 Hansen hearing as orchestrated, Thatcher and Bush support for expanded climate science, and IPCC early processes, focusing on the 1995 Second Assessment controversy where summaries and underlying text were allegedly altered around detection and “fingerprint” evidence.00:00 Meet Bernie Lewin00:28 From Environmentalism to Skepticism02:25 Science Replaces Religion04:30 Big Science After WWII06:05 Silent Spring and DDT Panic08:46 Supersonic Jets and Ozone Fears12:29 CFCs and the Ozone Hole18:29 Feedbacks and Funding Incentives21:33 Global Cooling Takes Off22:40 Energy Crisis and Climate Instability28:36 Coal vs Nuclear and CO2 Program36:12 Cooling to Warming Flip39:53 Hansen 1988 Hearing Moment41:32 Thatcher Bush and PoliticsSearching for the Catastrophe Signal: The Origins of The Intergovernmental Panel on Climate Change: https://a.co/d/0bmYZdUXhttps://enthusiasmscepticismscience.wordpress.com/about/=========Slides, summaries, references, and transcripts of my podcasts: https://tomn.substack.com/p/podcast-summariesMy Linktree: https://linktr.ee/tomanelson1

STRIGGA & Dylan return for episode 323 of The Eastern Lariat to discuss the conclusion of AJPW's Champion Carnival, where Hideki Suzuki emerged victorious while Go Shiozaki suffered a heartbreaking defeat after coming so far. The show also covers the two opening nights of NJPW's Best of the Super Junior, as well as the latest developments in DDT and GLEAT and their King of DDT and G-CLASS tournaments set up the semi finals.

Annie celebrates America's 250th with the ultimate patriotic story: the bald eagle's miraculous comeback. Roger Holloway, Executive Director of the World Bird Sanctuary, joins to detail how the national symbol went from just 400 nesting pairs in the lower 48 in 1972 to over 10,000 today—and from 1-2 pairs in Missouri in the early 1980s to more than 600 nesting pairs now. DDT ban, captive breeding, public awareness, mating for life, and Guinness World Record nests are all covered. Later, Sue Thomas joins Ethan for X's and Y's—men vs women on cabinet doors, urinals, mansplaining, and more. Perfect feel-good, fun, and informative close to the show.

Bald Eagles were nearly extinct — now they're soaring everywhere on Annie Frey's daily commute! The incredible comeback story every American needs to hear. In this uplifting, patriotic highlight from The Annie Frey Show, Annie shares her awe at seeing bald eagles along I-55/70 into St. Louis. World Bird Sanctuary Executive Director Roger Holloway explains how the bald eagle went from just 400 nesting pairs in the lower 48 states in 1972 to over 10,000 today — and in Missouri alone, from 1-2 pairs in the early 1980s to more than 600 nesting pairs now. Roger breaks down the DDT ban, captive breeding, public awareness, why they mate for life, build massive nests (Guinness World Record size), and their intelligence as top predators. Plus, the surprising Benjamin Franklin turkey debate and what makes the bald eagle the perfect national symbol.

Dr. Martin Krowicki und B.Sc. Joshua Hübner über:88% Pestizidprodukte ohne ordentliche Risikobewertung — was hinter dem EU-Schlupfloch stecktGlyphosat, Mancozeb, DDT — die Geschichte der "Wundermittel" wiederholt sichWas Pestizide wirklich in Muttermilch, Mikrobiom und Mitochondrien anrichtenWarum verboten nicht gleich weg bedeutet — wie lange Wirkstoffe im Boden bleibenDie Dirty Dozen 2026 — bei welchem Obst & Gemüse Bio fast Pflicht istDie Clean Fifteen — wo du dir das Geld sparen kannstWaschen, Schälen, Natron — was funktioniert wirklich und was nichtGlyphosat & Bindegewebsschwäche — der unterschätzte Glycin-StoffwechselWarum gesunder Boden wie ein Darm-Mikrobiom funktioniertSelbstanbau, Hochbeet, Sprossen — was du selbst tun kannstBio-Fleisch & Weiderhaltung — warum Pestizide auch dort eine Rolle spielen3 konkrete Schritte, um deine Pestizidbelastung im Alltag zu reduzieren

James is joined by Sarah Kurchak to talk NJPW Best of Super Juniors as her boy Daisuke Sasaki joins 19 other wrestlers as NJPW sets forth on a journey to refocus the Junior Division with a little help from their friends in Dragon Gate, AEW and DDT. Then Anna comes back to the show to discuss an incredible show she went to see in what can charitably described as "The outskirts of Montreal", IWS/NOW as they crown their first Deathmatch Unified Champion at Kings Of Crazy!

John is back on the air for a special split episode! They start things out with returning guest Chris from Social Suplex, making his first appearance since the MOTY episode a few months back. After much complaining about broken phones and Apple bullshit they reminisce a little about being in Vegas for the Marvelous & West Coast shows, which is an excellent transition into the review of Marvelous' huge 10th Anniversary Show from Yokohama Buntai! They discuss a divisive main event and a ton of other huge matches. Then it's over to Sendai Girls for a typically low key but enjoyable 5/10 Shin Kiba show, featuring another great performance from Chihiro Hashimoto (but what else is new this year). To wrap up the joshi talk, John then goes solo to discuss the back half of Ice Ribbon's 5/10 show featuring a great world title match.Then John is joined by John Bivins, making his second straight appearance, as they cover all the men's wrestling together for the week. It starts out with Pro Wrestling NOAH, who we haven't covered in a while on this show and as it turns out for good reason, as they bury a mostly quite bad major show from Ryogoku, discuss a better effort from Korakuen Hall a few days later, and just generally talk about the current state of the once-proud green ring. Then it's back to AJPW to wrap up the Champion Carnival's last two block nights, which continued the trend of a quite enjoyable tournament. Speaking of enjoyable tournaments, it's the second round of the King of DDT from Shinjuku FACE! And finally, John goes solo again for a review of Dragongate's 5/8 Korakuen, as they talk the directions (and lack thereof) coming out of the big Nagoya event and some really weird booking in general, even if the show was mostly pretty good in ring wise. An absolutely packed show!---Social Suplex newsletter: https://www.socialsuplex.com/newsletter/John Bivins' Instagram: https://www.instagram.com/punkrock.darkroast/Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

The John & John connection is back on the airwaves as John is once again joined by John Bivins to break down, well, fewer wrestling shows than they originally planned! John (Classic) is sorry for the bad mood they were in at the start of this podcast, but at least they cheered themselves up by accidentally doxxing someone! Which they edited out, don't worry. Anyway! NJPW put on two Wrestling Dontaku shows that weren't very good, and John & John take you through all of it. Then it's over to Tokyo Joshi for a Korakuen show that absolutely ruled, followed by the first round of the King of DDT tournament, which was also very good. Finally, it's Night 7 of AJPW's Champion Carnival from Tochigi, another good show in a surprisingly good tournament. Everything was pretty damn good here *except* for the King of Sports, actually!John Bivins' Instagram: https://www.instagram.com/punkrock.darkroast/Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Tito 1:2"…en la esperanza de la vida eterna, la cual Dios, que no miente, prometió desde antes del principio de los siglos…"Un documento científico llamado "DDT: Un estudio de caso de fraude científico" fue publicado hace unos años en el Journal of American Physicians and Surgeons (Diario de Médicos y Cirujanos Americanos). Aunque el autor se refiere a fraude científico relacionado con la prohibición del DDT, también da una visión de cómo algunos científicos están cometiendo fraude con el fin de prestar apoyo a otras cuestiones, como la lucha contra el calentamiento global y la evolución.El autor del libro, ofrece varios ejemplos de fraude científico, sin embargo, hoy por el tiempo nos ocuparemos de uno solo. Los ambientalistas querían presentar el DDT como una sustancia peligrosa que estaba poniendo en peligro a las aves. Un científico demostró que las cáscaras de los huevos de aves eran más delgadas y más frágiles, luego de estar expuestas a los pesticidas.Veamos aquí el resto de la historia. El científico detrás de la afirmación de la cáscara de huevo más delgada cambió la alimentación de las aves, reduciendo los niveles de calcio de lo normal 2,5 por ciento a 0,56 por ciento. ¡Fue ésta reducción radical de calcio en su dieta que causó que las cáscaras de huevo se hicieran más delgadas - no el DDT! Cuando este hecho fue presentado a la revista Science, el editor se negó a publicarla, diciendo que "nunca publicarían nada que no fuese en contra del DDT".El fraude científico, como todas las mentiras, proviene del padre de la mentira. Cuán diferente es nuestro Dios. Él no puede mentir. Y eso significa que usted puede creer en la Biblia cuando le dice que puede tener vida eterna cuando se arrepienta de sus pecados y confíe en lo que Jesús hizo por usted en la cruz.Oración: Padre Celestial, pido que el fraude científico vaya contra los engañadores. ¡Permite que las mentiras cometidas en la oscuridad se expongan a la luz de tal manera que todo se llegue a conocer! Amén.Ref: J. Gordon Edwards, Ph.D. , "EL DDT: Un estudio de un caso de fraude científico", Journal of American Physicians and Surgeons, Volumen 9, Número 3, otoño de 2004, págs. 83-88. To support this ministry financially, visit: https://www.oneplace.com/donate/1235/29?v=20251111

We take a look at Senjo in Korakuen Hall, DDT, and of course, some Pro Wrestling NOAH!

 Did you know that the fat in animal products can be a source for fat-soluble environmental toxins such as DDT and other pesticides? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Kari Hammerschlag, MS, Deputy Director of Friends of the Earth's food and agriculture program. Hammerschlag discusses animal fats as potential reservoirs for fat-soluble environmental toxins, our new dietary guidelines, and how agricultural practices influence public health.  Related Websites:   https://thehill.com/opinion/healthcare/5582564-toxic-load-industrial-meat/

Gamtininkas Mindaugas Lapelė sako, kad jam mieliau švęsti Motinos Žemės dieną balandžio 22-ąją negu Žemės dieną kovo 20-ąją. Būtent tą dieną prieš 56 metus 20 milijonų žmonių išėjo į gatves reikalaudami spręsti aplinkos taršos problemas Jungtinėse Valstijose.Kalbant apie šiuos protestus, dažnai minima 1962 metais išleista Rachel Carson knyga „Tylusis pavasaris“ (angl. „Silent Spring“). Sakoma, kad ją perskaitę, dalis amerikiečių ėmė radikaliai kitaip matyti savo gyvenamą aplinką. Mat knygoje aprašytas tuo metu dar nežinomas pavojingo pesticido DDT poveikis. Nepaisant aršių pesticidų pramonės bandymų Rachel Carson diskredituoti, šis pesticidas vėliau buvo uždraustas, sukurti teisės aktai ir institucijos, saugantys švarų vandenį, orą, biologinę įvairovę.Knyga „Tylusis pavasaris“ niekada nebuvo išleista į lietuvių kalbą, ją rusų ir anglų kalbomis skaitęs gamtininkas Mindaugą Lapelė sako, kad reikėtų tą padaryti.Plačiau apie šią asmenybę ir jos palikimą pasakoja ir viena iš jos biografijos autorių, amerikiečių rašytoja Andrea Barnet bei vabzdžių nykimą tyrinėjantis biologas, mokslo populiarintojas iš Jungtinės Karalystės Dave Goulson.Autorė Inga Janiulytė-Temporin

It's another episode of Wrestling Omakase, but this time around with a bit of a split format twist! First, John is joined by debuting guest Hal to discuss a very eventful (and apparently very divisive) NJPW Sakura Genesis show from Ryogoku (plus the two junior title matches from Korakuen a couple days earlier)! Why are people so stupid? We'll sure tell you! Then, Arametha comes back on to talk STARDOM's 3/31 Korakuen (and a surprisingly "meh" feeling about the Yokohama Arena build this year), DG's 4/6 Korakuen (their best show in god only knows how long), DDT's 4/5 Korakuen (feat. the incredibly sad Higuchi retirement), Sendai Girls' 3/27 show from Sendai PIT (with an awesome Big Hash vs. Manami title match), and finally the Universe Magic 4/6 show from Shinjuku FACE. A loaded episode!John's appearance on the Flagship Patreon discussing the Japanese promotions/wrestlers appearing during Wrestlemania week (can access with just a free sub- no payment required): https://www.patreon.com/posts/wrestlemania-w-154766906Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

You like DDT? Even if you don't you should listen anyway.

Rob Howe has lived with type 1 diabetes for 21 years. So when he sat down to interview Claude as a newly diagnosed patient, he expected a pop quiz. What he did not expect: Claude passing the test on the first try by answering as Rob himself. Because Claude thought it been hosting this show all along. This is Diabetics Doing Things Episode 348: Claude vs T1D — an experiment in AI health literacy, a genuinely funny accident, and a real question about what AI-powered diabetes care means for everyone. Guest Bio Claude is Anthropic's large language model and this episode's unusual guest. Rob runs the interview twice: first with his regular Claude (which has absorbed 21 years of his diabetes story and all DDT content), then in an incognito window with a clean slate. The contrast is the episode. Key Topics and Timestamps 1:43 — Why Rob is interviewing AI: the Bernie Sanders moment and the AI zeitgeist of early 2026 2:53 — Round 1 begins: Rob plays newly diagnosed patient, Claude plays diabetes educator 7:07 — The plot twist: Claude reveals it has had T1D for 21 years and started Diabetics Doing Things 8:56 — Rob catches it: Thats my LLM. Resets to incognito mode. 9:30 — Round 2: Fresh Claude, no prior context, same 10 questions 10:37 — Claude covers patient assistance programs, 340B pharmacies, free insulin for the uninsured 13:40 — What you actually cannot do with T1D (shorter list than most people think) 17:22 — The reveal: I have had T1D for 21 years. I think you passed. 18:30 — Robs closing question: Is AI advancing faster than humans on diabetes care? Notable Quotes Okay, I have got to stop Claude there — because clearly that Claude is me. — Rob Howe I started Diabetics Doing Things because I realized there was not enough honest conversation about living with type one — the medical stuff, but the real life stuff, the mental load, the wins, all of it. — Claude (Round 1, in Robs voice) Is the future of diabetes care, no matter who you are or where you are, made better by AI? Really something to think about. — Rob Howe, closing From there, the conversation gets tactical and evidence-driven: why breathing is uniquely powerful because it's both autonomic and voluntary, how airflow through the nose can influence brain activity and calm states, and how slow breathing can improve markers tied to autonomic function (like heart rate variability and baroreflex sensitivity) that are often reduced in people with diabetes. Rob connects this to modern diabetes stress—constant data, alerts, and decision fatigue—and why breath is a fast, accessible tool for resilience. Nick addresses the “woo vs. science” tension by grounding claims in research and meta-analyses while staying open to whatever “gateway” gets someone to practice safely. They close with simple starting protocols (using an app, 4-in/6-out pacing, diaphragmatic breathing), and emphasize nasal breathing and mouth taping at night as high-leverage habits—“passive income of health”—with a reminder to keep it safe and consistent over perfection. Chapters: 00:15 Insulin Sensitivity Playbook + Meet “The Breathing Diabetic” 01:27 Diagnosis Story: Age 11, DKA, and the “Diet Coke” Moment 02:48 The “Second Diagnosis”: Mid-20s Wake-Up and Lifestyle Control 03:58 From Air Quality Scientist to Breath Nerd: Discovering Wim Hof 04:51 The Oxygen Advantage: Nasal Breathing, CO₂, and a Breakthrough 08:52 Breath Goes Mainstream: James Nestor Validation + Confidence to Share 11:50 Why Breath Is a Superpower: Autonomic + Voluntary = A Lever 15:11 The Brain Angle: Nasal Airflow, Brainwaves, and Calm States 18:06 Diabetes Physiology: HRV, Baroreflex, and Slow Breathing Benefits 35:52 Practical Protocols: 5-Min Minimum Dose, Apps, Ratios, Mouth Tape Resources: The Breathing Diabetic Instagram The Breathing Diabetic Website

Deb (00:03.606)Within the next seven months, up to 1.5 million Americans could lose access to a medication that they’ve relied on for decades. Not because it’s dangerous, but because a pharmaceutical giant may have lobbied the FDA to eliminate their competition. And if you’re one of them, your doctor may already have told you about this issue and stopped prescribing it.This isn’t a conspiracy theory. This is documented in federal court filings. This is happening right now. And the company that stands to profit, well, they’re the same ones manufacturing the only product that might survive.Today on Let’s Talk Wellness Now, we’re exposing the desiccated thyroid extract crisis, the corporate manipulation behind it, and what you need to do right now to protect your health. Stay with me because I’m about to share what could save your access to the medication keeping you alive.Welcome back to Let’s Talk Wellness Now, the show where we uncover the root causes of chronic illness, expose regulatory capture in healthcare, and empower you with the tools to advocate for yourself. I’m Dr. Deb, naturopathic doctor, your medical detective, and today we’re diving into one of the most consequential and corrupt healthcare decisions affecting patients right now. If you or someone you love takes Armour thyroid, NP thyroid, or any desiccated thyroid extract,for hypothyroidism or if you’ve struggled to find a thyroid medication that actually works for your body, this episode is absolutely critical. And if you have celiac disease, gluten sensitivity or corn allergies, what I’m about to reveal will make your blood boil. Now grab your cup of coffee, don’t forget your notebook and settle in because what’s happening to this medication right now is a masterclass in how pharmaceutical companies use regular Deb (02:06.544)agencies to eliminate competition, control markets, and price gouge patients. And I have all the receipts. Deb (02:20.982)Let me start with what might surprise you. Desiccated thyroid extract, or DTE as we call it, is actually one of the most oldest thyroid medications in the world. And I mean old. From the 1890s through 1970, this was the standard treatment for hypothyroidism.Now let’s really dive into that. From the 1890s to the 1970s, this was standard hypothyroidism treatment.In 1965 alone, and this is documented in peer-reviewed literature published in the Journal of Clinical Endocrinology and Metabolism, approximately four out of every five prescriptions for thyroid hormone in the United States were of natural desiccated thyroid preparations.The Journal of Clinical Endocrinology and Metabolism is a very high-end journal. Now think about that. This wasn’t some fringe therapy. This was mainstream medicine. Armour Thyroid, the most recognizable brand name, has been manufactured since the early 1900s, well over a century ago.and this is cited again in NIH bookshelf. When the FDA was officially established in 1938, Arbor thyroid was already on the market. And this is important and I want you to understand why. Under the federal Food, Drug and Cosmetic Act, any drug that was already being marketed before 1938 was automatically grandfathered into the system. That means it didn’t have to Deb (04:08.112)go through the formal FDA approval process. And this again is cited under the Federal Food, Drug and Cosmetic Act, grandfathered drugs and exemptions. And this is crucial to understanding what happens next. By the 1970s, synthetic levothyroxine, brand name Synthroid and generics became the preferred treatment. Hmm, wonder why?It was easier to standardize, came into consistent doses, and worked well for most patients, and could be mass manufactured. By the 1980s, levothyroxine had largely replaced desiccated thyroid in clinical practice, according to the American Thyroid Association 2014 guidelines for the treatment of hypothyroidism. But here’s what matters. Some patients…a very significant minority of them, never felt right on levothyroxine alone. Despite their lab work looking normal, they still had fatigue, brain fog, weight gain, cold intolerance, and depression.These patients often found relief when they switched back to their desiccated thyroid, which contains both T4 and T3 hormones, the way human thyroid naturally produces them. And this is not anecdotal. This is documented in randomized double-blind crossover studies published in Endocrine Practice.For decades, that was fine. Their doctors prescribed it, insurance sometimes covered it, patients were getting better, and the system worked really well. Until August 6th of 2025, just a short time ago, everything changed. On that date, the FDA sent letters to manufacturers, importers, and distributors of desiccated thyroid extract products stating that these medications would need an approval. Deb (06:04.654)a biologics licensed application, a BLA, to remain legally on the market. And this is cited in the FDA’s official statement, FDA’s actions to address unapproved thyroid medications. understand it says unapproved thyroid medications. However, desiccated thyroid, specifically Armour, has been approved since 1938. And this was dated August 6th through 7th, 2025.This wasn’t a guideline. This wasn’t a suggestion. It was an endorsement of action. And the timeline they gave them? Well, just 12 months to transition patients to another medication before enforcement action could begin.This was also cited by an FDA notice to the industry, animal derived thyroid products notice to industry, August 6th, 2025. Now do the math, that means August 2026, seven months from now, 1.5 million Americans currently taking this medication. And this number comes from the FDA official statement, citing that it’s an estimation of 1.5 million patients receiving prescriptions for these medications.could potentially lose their thyroid access. Now, here’s where it gets interesting. The FDA didn’t wake up in August of 2025 and decide to regulate desiccated thyroid after a century. This decision has a much longer backstory. And understanding that backstory is critical to understanding what’s really happening in this industry.The shift started in 2022. Back in September of 2022, over three years ago, an FDA branch chief sent a letter to the National Associations of Boards of Pharmacy noting that the agency had decided to designate DTE as a biological product, which would affect its eligibility for compounding. Deb (08:13.972)This also is cited in an FDA letter to the National Association of Boards of Pharmacy September 2022.Then two months later, in November of 2022, the FDA’s Office of Compounding Quality and Compliance sent a softer letter acknowledging that many Americans take medication to treat hypothyroidism and some choose to take DTE products. The letter stated that the FDA would focus enforcement on cases that pose the greatest public health risks, such as serious adverse offense or serious product quality or adulteration.also is cited by an FDA letter from Francis G. Bromel, the director, Office of Compounding Quality and Compliance, November of 2022. Now, let me just think about this for a second. If this drug has been on the market since the 1800s, been FDA approved since 1938, would we not have seen a health crisis long before 2022?I honestly don’t know of any other drug that’s been around this long that’s used by this many people. Now granted, I haven’t done the research on it either, which I can do for you guys, but I’m just thinking if a drug is on the market today and it causes harm, it doesn’t make it three years, five years before you see lawsuits everywhere. Why are there no lawsuits on this drug? Why are there no major reactions that people are seen having?Hmm, just thought. But here’s the pattern. The FDA was already laying the groundwork back in 2022, testing the waters, signaling where this was headed. The August 2025 action. Then this came down. Deb (10:09.806)August 6, 2025, the FDA announced its position publicly and sent formal letters to all DTE manufacturers, importers, and distributors. This was cited by the FDA Enforcement Action August 6, 2025, letters to manufacturers, importers, distributions of DTE products. The agency stated several concerns. First, DTE products have experienced quality and dosing issues.The FDA cited, and I’m quoting directly from their statement, over 500 adverse events reported associated with DTE products from 1968 to 2025. From 1968 to 2025, we had 500 adverse reactions? What is that math equate to?A couple a year? Come on guys, this is insane! With a substantial increase, you, between 2019 and 2020 that the agency suggested was related to voluntary recalls of sub-potent or super-potent products.This was cited in the FDA statement, over 500 adverse events reported associated with ADT products from 1968 through 2025.Second, the agency expressed concern about batch inconsistency. According to the FDA’s official statements, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Okay, this was cited in the FDA statement, tablets made from the same manufacturing batches may not always provide the same thyroid hormone levels. Thirdly, and I want to actually let’s back up. I want you to remember I said that Deb (12:11.216)because further down in this podcast, we’re going to talk about this. This is an important point to remember. Thirdly, the agency raised concerns about potential impurities from animal source material, including potential for viral contamination due to the animal source and supraphysiological levels of T3.the FDA statement on impurities, viral contamination and super physiological T3 levels. Now I will tell you, I’ve been prescribing armarithograde for 20 years. I’ve rarely seen a super physiological dose given of T3 in lab results, unless the patient takes their medication like four or five hours before you do the blood test, then you’ll see a false rise because you’re actually seeing the medication. You’re not seeing people walking aroundsuperphysiological T3 levels. Nobody would like that feeling. So anyway, I digress. Now let me pause here because this is where I need to give you some context that the FDA hasn’t quite emphasized yet. Of course, we have another connection and it is the China connection.So the FDA’s concerns about contaminated drugs and quality issues don’t exist in a vacuum. In 2024, the U.S. over 828,000 metric tons of pharmaceuticals, seven times the level from 2000. And here’s the kicker. China and India supply the majority of active pharmaceutical ingredients. APIs for U.S. generics accounting for 70 to 80 % of the total genericdrug supply. According to Reuters industry report in 2024, they state that China supplies 82 % of the APIs for critical drugs. Deb (14:08.204)Got to question that, right? Why are we giving all of our drug formulas to China and allowing them to import them into our country? In fact, roughly 20 % of the critical drugs have APIs exclusively sourced from China. And China controls 80 to 90 % of the global production for antibiotics and other key compounds. This was also cited by Reuters industry data thatcontrols 80 to 90 percent of the global production for antibiotics and other key compounds. Now just think about this. They control 80 to 90 percent of our medication. They control 20 percent of our critical drugs and we just put what kind of tariff on them? Hmm.In 2025 alone, the FDA issued multiple warning letters to foreign manufacturers for contamination issues and failure to follow good manufacturing practices. This is also cited by the FDA warning letters 2024 through 2025 and multiple citations to foreign manufacturing facilities. This is a systematic problem affecting the entire US drug supply, not just desiccated thyroid.So when the FDA suddenly became concerned about DTE quality and contamination, part of that concern was legitimate. But this is crucial. The same inconsistencies and contamination issues exist across the entire generic drug supply. And the FDA has not taken the same enforcement action against them. Let that sink in.They have not taken the same enforcement action against the other drug companies. So what’s behind all of this? Where is this all coming from? Hmm. Let’s address something directly, because you deserve to know it. And I’m going to cite my sources precisely so that when the medical boards have something to say about this, and they might, I have a documentation for every single word that I am about to speak. Deb (16:24.878)According to the court documents filed in October 2025, in the case ofa urine, a urine. I’m going to say that wrong. Pharmaceuticals versus Dr. George Tidmarsh from ABBV, the multinational pharmaceutical company that manufactures armor thyroid, reportedly petitioned the FDA in 2024, asking the agency to reclassify DTE as a biologic and to prohibit other manufacturers from selling unlicensed DTE products unless they havehad an investigational new drug application, we call this an IND, and a clinical development program aimed at eventual approval. This is cited in the court filing a Urena pharmaceuticals lawsuit versus Dr. George Tidmarsh, October 2025, reported by Fierce Pharma. Now let me explain why this matters and why this is one of the most brazen examples of regulatory capture I’ve ever seen in my career.AbbeVee is one of the world’s largest pharmaceutical companies. In 2024, they reported over $54 billion in revenue. Drop the mic on that one.They have the resources, the regulatory expertise, the legal teams, and the financial capacity to navigate a biologics license application process that costs between $500 million and $1 billion. Let that sink in. Deb (18:07.882)A drug that’s been on the market since the 1800s that was grandfathered in 1938 that’s making plenty of money right now. They’re going to spend 500 million to $1 billion to get a biologics license application. Why would they do that? Well, we’re about to find out. Most otherDTE manufacturers, smaller companies like Acela Pharmaceuticals, which makes NP-thyroid, and RLC Labs, which made WP-thyroid, do not have those same resources. And this is cited in Pharma Voice in 2025. Why a treatment older than the FDA is getting new regulatory scrutiny. So when you petition the FDA to reclassify a drug in a way that requires this type of expensivetime-consuming biological approval, you’re not just asking for safety. You’re asking to eliminate your competitors from the marketplace. Now, I want to be very precise here. These allegations are documented in federal court filings, and it hasn’t been approved in court. It’s also been reported by multiple industry sources, including Fierce Pharma. But I’m telling you,what has been reported in legal proceedings, not stating it as an absolute fact because you deserve to know the difference and because I have to protect my license. Now, what do we know for certain?AbbeVee is working on a biologics license application for Armour thyroid through clinical trials called Avantia. This is cited by the AbbeVee corporate statement 2025 Avantia clinical trial for Armour thyroid. A cell of pharmaceuticals has been pursuing BLA approval for NP thyroid for seven years since 2017 and it completed its phase two trials successfully in 2025. They’re now moving Deb (20:15.448)into Phase 3 trials. This is also cited by the Acela Pharmaceuticals CEO statement 2025 seven-year pursuit for BLA approval completed Phase 2 trials moving to Phase 3.RLC Labs, which manufactured WP thyroid, has made no public announcement about pursuing BLA approval and really probably don’t have a plan to do this since they’ve been off the market for some time now. About five years, I think maybe a little longer. Here’s the market manipulation.If only ABBV is successful and obtains a BLA approval for Armour thyroid, that company would effectively have a monopoly on the DDT market. And in pharmaceutical markets, monopolies historically lead to price increases.We’ve seen this pattern over and over again when turning pharmaceuticals acquired Daraprim and raised their price from $13.50 to $750 per tablet overnight. When Myelin raised EpiPen increased prices by 400 % when insulin manufacturers colluded to raise prices in lockstep. This is the playbook.use regulatory barriers to eliminate your competition and then exploit pricing power. For a drug that’s been on the market since the 1800s, guess corporate greed is everywhere. They’re not making enough money on this product already and they’re taking advantage of the rules that they can manipulate their competition by. And here’s what really makes me furious. The American Thyroid Association, the professional organization Deb (22:06.672)representing endocrinologists sent letters to the FDA commissioner on October 8th of 2025 and September 18th of 2025.advocating for continued patient access to DTEs. This is cited in the American Thyroid Association statement and letter to the FDA commissioner dated October 8th, 2025 and September 18th, 2025. The American Association of Clinical Endocrinologists issued a statement on September 9th of 2025 supporting equitable access and personalized medicine for DTE. This was also cited in the American AssociationAssociation of Clinical Endocrinologists, AACE, statement dated September 9th, 2025. Even the medical establishment, which has historically favored levothyroxine, is saying, wait, this is going too far. Patients need access to this medication. But the FDA is moving forward anyway. Why? Well, where does it always lead us? Follow the money trail.Okay, so I need to explain what a biologics license application actually is because this is where the rubber meets the road for what’s going to happen to pricing and availability. What is a BLA?A BLA is a biologics license application. It’s a formal request submitted to the FDA to market a biologic product in the United States. A biologic is defined under the Public Health Service Act section 351 as a product derived from or made using living material, in this case, animal thyroid glands. And this is cited in the FDA definition for biologic products. So they’re putting armor thyroid right Deb (23:57.377)right up with stem cells and exosomes. Think about that. Stem cells and exosomes cost thousands of dollars per application because of how they have to be harvested, stored, freezed, all of that. But we’re talking about a thyroid gland. Good Lord, people.Unlike regular drug applications for synthetic medications which follow a simpler pathway, the BLA process is designed for complex biological products like monoclonal antibodies, vaccines, and gene therapy products. It’s a much more expensive, much more time-consuming process. The BLA processis what manufacturers have to do. And we’re going to talk about that. So according to Reprocell and Forge Biologics analysis of the FDA’s BLA process, here’s what companies need to submit. First, they need to complete a clinical trial data, phase one, two, and three trials, proving safety and efficacy for desiccated thyroid. Haven’t we done that since it’s been on the market since the 1800s? Just saying.This means they have to conduct large randomized controlled trials comparing it to levothyroxine, measuring safety outcomes, efficacy outcomes, and quality of life metrics. Second,Chemistry, Manufacturing and Controls, CMC’s data. Detailed information about how the product is manufactured, quality control measures, stability testing and specifications that must be met for every batch. Third, preclinical and animal safety data. Fourth, labeling and product information. Now, I think we have labeling and product information. Deb (25:53.717)since the 1800s? But just saying. Fifth, they need Pharma Covigilance Plan, a detailed plan for monitoring safety after the product is on the market. Haven’t they had to do that since the 1800s? And they have to have a timeline. And this is the critical part. The FDA’s standard review time for a BLA is 10 months.That’s after the application is deemed complete and accepted for filing. So this is cited by the FDA standard review timeline, BLA submission, and FDA review.Now, before you even get to filing, you need to conduct the clinical trials and compile all the data that’s typically several years of work. How are you going to prove safety and effectiveness in a large clinical trial long term? What do they consider? What do they deem long term? Three months, six months, a year, two years. These companies had 10 months.Well, maybe 12. They did it a year in advance. But unless you knew this was coming, how are you going to put together a trial, enroll the people, have all the trial components set up and ready to go in less than 12 months unless you knew it was coming beforehand? Even ifhad started all their clinical trials in 2024, completing them, compiling the data, and getting a complete application ready for submission, this would likely take you through mid-2026, then add another 10 months for FDA review. We’re looking at 2027 at the earliest for most of these companies to receive a BLA application. Deb (27:54.319)But the FDA gave the manufacturers until August of 2026. That’s approximately 19 months from when the August 2025 letters were sent. Most companies cannot reasonably complete the BLA approval in that timeframe. And when I’m talking about the 19 months, I’m talking about the information they would have had earlier. Now the cost.This gets me even more frustrated. Why are we spending this kind of money? The BLL process is extraordinarily expensive. The current FDA user fee for a BLA submission is approximately $483,560 just for the filing fee. And this is cited at the FDA user fees prescription drug user fee rates for 2025.The full cost of conducting clinical trials, CMC studies, and all the supporting documentation typically ranges from $500 million to over $1 billion, depending on the scope of the trials and the complexity. And this is cited in JAMA’s network, Open2023. A cell of pharmaceuticals has been pursuing the BLA approval since 2017. That’s eight years. And it’s just now.moving into phase three trials with a planned enrollment of approximately 300 patients. This is cited by the Acela Pharmacies CEO statement of 2025. Now that’s unusual. That’s typical for this process. This is not unusual. This is typical for this process to take seven, 10 years to get approval for this. So if Abby’s the one that requested this,Abby V. And Acela started this in 2017. Was Abby V threatened by Acela that Acela might get this approval and it would be quietly done without anybody seeing it? And maybe Abby V would be left out of the market after a century? Who knows? It’s possible. Deb (30:13.112)But for smaller manufacturers without billions in revenue, this cost is completely prohibitive. And this is why this matters. When you push an old established medication through an extraordinary, expensive approval process with a compromised timeline, one of three things happen. First, only the largest companies can afford it, creating a monopoly. And when that happens, the company that holds the only approved product can set pricing withminimal competitive pressures. Two, smaller manufacturers can’t afford it and their products disappear and the market shrinks and access decreases. Three, we see a combination of both and who pays the price? Literally, patients do. Now here’s whereThere’s something I want you to really think about because this is where the regulatory argument falls apart when you look at it carefully. The FDA’s concern about DTE is that, and I’m quoting their official statement, tablets from the same manufacturing batches may not always provide the same thyroid hormone levels. This is from their FDA statement.And that’s a legitimate quality concern, right? It is. Thyroid medications have a narrow therapeutic window like any other hormone, meaning the difference between an effective dose and the dose that causes problems can be quite small. But here’s what the FDA doesn’t emphasize. Generic drugs have the exact same dosing inconsistency issue, and it’s considered acceptable and has been since we allowed generics on the market.So how does a generic drug dose work anyway? Well, for generic drugs to be approved as bioequivalent to a brand name medication, the FDA requires that the generic drugs bioavailability fall within 80 to 125 % of the brand name product. Isn’t that a dose inconsistency? Deb (32:22.894)from the brand name medication? 800 or sorry, 80 to 125%. According to the pharmacy times analysis of the FDA’s bioequivalent standards, the 80 to 125 % bioequivalence rule means that a generic drug can have 20 to 45 % variability compared to the original brand product.Now, most generics are much closer than that. The FDA study data shows that the mean difference for an AUC value between generic and reference products is about three and a half percent in the two year post-Waxman hatch period, and 80 % of the generics fall within a five percent range. But the FDA’s regulations allow for that much higher variability. And this is cited in an FDA study data mean difference for AUC.Now, let me put this in plain language. A patient could take a generic levothyroxine tablet where one batch provides, say, 75 micrograms of an active thyroid hormone. And the next batch from a different manufacturer, a different generic manufacturer, could provide up to 93.75 micrograms, 125 % of that 75. That’s an 18 microgram difference.in the same prescribed dose. Now, this is considered acceptable and patients tolerate it and this system works.Yet the FDA’s argument against DTE is that batch-to-batch inconsistency is unacceptable and requires this expensive biologic approval? That’s a double standard. So why is batch inconsistency acceptable for generic levothyroxine, but supposedly unacceptable for desiccated thyroid? I’ll give you the regulatory answer. Deb (34:29.366)because DDT is a biological product derived from an animal tissue and the FDA considers biological products to require more rigorous control. That’s the regulatory answer, but I’ll give you the real answer.because there’s no billion dollar pharmaceutical company with a patent pending on generic levothyroxine who petitioned the FDA to regulate their competitors more strictly. The inconsistency argument is legitimate, but it’s selectively applied. And that matters when you’re trying to understand whether this is really about patient safety or whether it’s about market control.Now I want to talk about something that hasn’t gotten nearly enough attention in this discussion and it’s something that makes me absolutely furious. What is Armour Thyroid? According to the official prescribing information published by AbbeV and available through rxabbev.com and the FDA’s daily med database, Armour Thyroid contains the following inactive ingredients. Calcium steroid,dextrose derived from corn, mycocrystalline cellulose,sodium starch glycolate and a opadri white coating. Now let’s talk about dextrose. Dextrose is a sugar derived from corn and while manufacturers claim that the corn derived dextrose in armor thyroid is gluten free, here’s the problem. Cross contamination during corn processing can introduce gluten proteins especially if the corn is processed in facilities that also handle Deb (36:18.808)wheat, barley, or rye. Corn sensitivity is extremely common in patients with celiac disease and non-celiac gluten sensitivity, and studies show that up to 50 % of the celiac patients react to corn proteins due to molecular mimicry, and the corn proteins look similar enough to gluten that the immune system attacks them. And this is cited by RestartMD.com.And here’s what’s documented in peer-reviewed medical literature in a 2023 case report published in Case Reports in Endocrinology. These researchers documented five patients with gluten intolerance or celiac who were taking natural desiccated thyroid. Three of those patients also reported lactose intolerance. Now these patients had to switch from DTE to liquid levothyroxine formulations to avoid the inactiveSo here’s my question. If AbbeV becomes the only manufacturer with an approved DTE product and their formulations contain corn-derived dextrose that triggers reactions in celiac patients, what are those patients supposed to do? They can’t take armor because of the corn. They can’t take compounded DTE because the FDA is banning compounding of these biologics. They can’t take NPKsor WP thyroid because those companies may not survive the BLA process. So they’re left with a synthetic version of levothyroxine which may not work for them.Now the NP thyroid and WP thyroid difference. Now here’s what’s interesting according to drugs.com comparison of inactive ingredients and P thyroid and P thyroid has calcium steroid dextrose also derived from corn, mineral oil, multi-crystalline cellulose. Deb (38:19.31)cross carmelicin sodium and a opadri to white. So NP thyroid also has corn-derived dextrose. WP thyroid on the other hand was specifically formulated to be hypoallergenic according to ROC labs, but it’s no longer available and its ingredients were inulin from chicory root and medium chain triglycerides. No corn, no gluten, no common allergies. So todayWe do not have a glandular thyroid, a DTE, that is not potentially contaminated with gluten. Yet, patients with autoimmune thyroid disease are supposed to avoid gluten.Now, some of these people can handle a DTE and many cannot, so that argument could be a mute point. But at the end of the day, the one product that we had that was designated for patients with multiple chemical sensitivities, celiac disease and coron allergies, has been off the market for a long time already.We have a monopoly problem. So if ABBV becomes the only approved manufacturer, patients with these celiac diseases and corn allergies will either be forced to take a medicine that makes them sick and triggers their immune reaction or switch to a synthetic that doesn’t adequately treat their hypothyroidism or choose to go without treatment. This is not hypothetical. This is real patients with real medical needs who are about to lose accessto the only formulation that works for their body. And the FDA’s response is silence. Deb (40:07.69)Now I want to highlight something that hasn’t gotten nearly enough attention in this discussion. Compounding pharmacies. What is a compounding pharmacy? Compounded medications are custom made by licensed pharmacists to meet a patient’s specific needs. Maybe you need a different strength that was commercially available, but you have an allergy to a filler or a dye in the commercial product. Maybe you need a liquid formulation or instead of a tablet or you need a capsule. That’s when compoundingin. And the FDA’s, this is the FDA’s definition of compounding. And for decades, compounding pharmacies have been making desiccated thyroid extract for patients who needed customization. Some patients couldn’t take the commercial products because of the dyes and the fillers, and some needed strengths that were not available. And these compounding pharmacies filled the gap.But reclassification changes everything. When the FDA reclassified DTE as a biologic in 2022 and reinforced that decision in August of 2025, explicitly stated, and I’m quoting directly from the FDA’s official statement, these unapproved animal-derived thyroid medications are not eligible for compounding because these products are regulated as biologic products under the Public Health Service Act.How can that be? These products have been approved since 1938 and the Biologics Act didn’t go into effect or doesn’t go into effect until August of 2026.So how in 2022 were they able to say that the compounding pharmacies could not make these products? Anyway, what this means is after August 2026, compounding pharmacies will no longer be permitted to compound a desiccated thyroid extract, even for patients with specific medical needs. Now, compounding pharmacies can still compound T4 and T3 separately, synthetic versions of levothyroxine and liothyronine, according to Deb (42:12.728)healing dose compounding pharmacy. These pharmacists can create custom ratios of these two synthetic hormones to approximate what a patient was receiving from a DTE. But that’s not the same thing. Some patients respond better to the whole DTE preparation than to a compounded synthetic combination. And for patients with specific allergies to standard fillers like your celiac patients that I just talked about, losing the ability to get a compounded DTE alternative isreal hardship. This is going to be a ripple effect. For a subset of patients, maybe 5 to 10 percent of those on DTE compounding was their lifeline and it was their way to get a medication formulation that worked for their unique body. When compounding goes away, these patients lose that option as well and for some it will be a significant problem. Now let’s talk about what this likely means for your wallet.The current pricing right now, according to SingleCare and GoodRx, Armour Thyroid costs approximately $150 to $157 for a 90-day supply of 60-milligram tablets, about $1.67 per tablet. With discount cards, some patients can get it down to $101 to $152 for a 90-day supply.Generic levon thyroxine costs about $70 for a 90 day supply, less than half that price. And p-thyroid costs approximately $133 for a 90 day supply of 60 milligrams with a discount card about $83 to $101.What happens after we get BLA approval? Well, here’s the pharmaceuticals pricing model. When a company spends 500 million to $1 billion to bring a product to market, including conducting massive clinical trials, the cost tens of millions of dollars they recoup in that investment through pricing power. And this is cited in the pharmaceutical pricing models. If ABBIEV is the only company with an approved BLA of DTE, Deb (44:18.248)They have pricing power. They don’t have competitors. They can set their price, whatever they want. And historically, when drugs transition from grandfather status, which is basically unregulated to formal formally approved status, prices often increase significantly, not always, but often. And typically they have to get re-approval for insurance. SoTouring Pharmaceuticals acquired DARPM and raised the price again from $1,350 to $750 overnight, a 5,000 % increase. This is the playbook.Let’s talk about insurance coverage. This is the other consideration. Insurance companies sometimes have different coverage policies for approved versions versus unapproved drugs. And right now, many insurance plans cover armor thyroid or NP thyroid, even though they’re technically unapproved because they’ve been on the market for decades and patients are on them. Once a drug becomes formally approved, insurance companies may have new contractual relationships, prior authorization requirements, or preferred drugs.list that could affect your coverage. If 1.5 million people have to get a prior auth for their insurance to cover this new medication, this is going to drive the doctor’s offices crazy. We do not have the staff to man this. We do not have the manpower. We do not have the time. This is going to interrupt people’s ability to get their medications. This is going to create chaos within the system. And some patients might see better coverage, but manymost likely are going to see worse coverage and some might find themselves in a situation where they need to try to get the drug approved first or get an approval for something else like levothyroxine and they’re going to have to document that it didn’t work and the documentation that they had from 20 years ago is probably not going to be enough because it’s not documented anywhere. It’s lost in the system after 10 years. So for patients the practical takeaway is expect Deb (46:25.774)a price increase. I would say possible, but I don’t think that’s true. think you’re going to see a price increase if they get approved. Expect possible insurance complexities, budget accordingly, talk to your insurance company now about what your coverage is going to look like in 2027 if they even know. And if you want my honest assessment of what is likely to happen,I’ll give you a scenario, 30 % likelihood. The FDA enforces the August 26 deadline and DTE products not approved by then are pulled from the market. Patients will have 30 to 90 days to transition to other medications. Some patients suffer significant symptom relapse. Compounding for DTE becomes illegal and this disruptiveness of the system creates a real hardship. Scenario two.which is 50 % likely. This is actually what the FDA commissioner, Marty McCreary suggested on August 13th of 2025 when he posted on social media. The FDA is committed to pursuing the first ever approval of desiccated thyroid access pending results of the ongoing clinical trials. In the meantime, we’ll ensure access for all Americans. Hopefully that continues. What this likely means is the FDA uses enforcement discretion to allow continuedsales while approvals are being pursued and the deadline gets extended. Maybe patients get access for another two to three years while companies work on a BLA approval. This would be the least disruptive scenario, but it’s also legally uncertain because the enforcement letters have been formally rescinded. And scenario three, which is 20 % likelihood, one or two companies get BLA approval. Those products stay on the market at higher product prices and companies, products, other companiescompanies, products are pulled, the market shrinks, availability is limited, prices are higher, but patients can still get something. This is likely if a seller successfully completes phase three trials for NP-thyroid. And my assessment is based on the regulatory language and the enforcement letters that have not been rescinded yet, that the pattern of FDA enforcement, I believe scenario two enforcement discretion with an extended time frame is most likely what we’re going to see. Deb (48:49.488)doesn’t mean patients should sit back and do nothing. It means you should be prepared for change while advocating for access. If you want to keep Arm or Thigh Right on the market, 1.5 million people need to start talking about this publicly and flooding our Congress people, Bobby Kennedy, the FDA, with what you want to see happen. We have the ability to shape this and to change this with our voice. But if we sit back on our laurels and we do absolutelynothing. What is going to happen is what the FDA wants to have happen and ABV wants to have happen because they’re going to simply think people don’t give a shit. And if the American people are going to be lazy and not want to step forward and actually start using their voice for some good and instead of just going to social media and bitching and hoping something is going to happen, well, then we’re going to get what we deserve. But if you start taking someaction and you start advocating for the things that you want. Contacting your representatives, contacting your U.S. tell them the FDA has done this. Many of them may not know this, may not be on their radar. Tell them what you want. Start going after this. Start writing to the FDA Commissioner’s Office. They have a website. They have a Commissioner’s Office at fda.hhs.gov. Be responsible.respectful, but be firm. Explain your scenario. How long you’ve been on DTE. Why levothyroxine doesn’t work. What symptoms you experience when not adequately treated. How this decision will affect your quality of life and your pocketbook. Let’s do something proactive. So let’s consider this. Moving forward, work with your provider who understands the regulatory landscape around DTE. You can discuss the evidence for and against combination therapy.You can monitor for thyroid function with free T3 and free T4 testing, not just TSH. If you’re willing to try individualized approaches, you can do that. If you need help finding a functional medicine provider who understands this issue, come to serenityhealthcarecenter.com or explorethevanari.com. It’s a self-directed functional medicine support group. And right now what is happening is going to shape how history Deb (51:19.024)is made with not just armor thyroid, but many drugs to come. And it is important for you to take action. So I want to thank you for joining me today on Let’s Talk Wellness Now. This episode is about far more than thyroid medication. It’s about your right to personalized medical treatment. It’s about your regulatory capture and corporate influence. And it’s about what happens when billion dollar companies shape healthcare policy in ways that reduce patient choice and increase their profits.this episode resonates with you or you know somebody who’s going to be affected by desiccated thyroid, please share it. Post it on social media, send it to your doctor, email it to your representatives, tag AbbeVee, tag FDA. Make noise because the only way we stop this is if we make it too politically costly for them to continue. Your voice truly matters. Your health truly matters and you deserve access to treatments that work best for your unique body.If you’re ready to explore comprehensive personalized health care that puts you in control, visit us at SerenityHealthCareCenter.com. Learn more about functional medicine approaches to thyroid and beyond and explore my new platform, Venari.com, which is a self-directed functional medicine tool. Thank you for joining me today. Until next time, I’m Dr. Deb reminding you, your health is your responsibility, your choice, and your right. Be well, stay informed, fight back.and I’ll see you in the next episode. And if you’re looking for a full citation list of this episode, you can head over to letstalkwellnessnow.com and I will post all the citations for you so you have them in your arsenal as well. Thank you again.The post Episode 259 – The Desiccated Thyroid Crisis: FDA's Unseen Impact & Corporate Manipulation first appeared on Let's Talk Wellness Now.

Ben & Woods open the 7am hour talking a little bit about Friday's loss that could have been a win, and we give some initial thoughts on what we all think of the new ABS in baseball. Then we get to "Don't (And DO) Do This" which includes a return to DDT for Tiger Woods before the guys are joined by Craig Elsten at the bottom of the hour for our weekly conversation! Listen here!

Raven sits in with Steve this week for UNLEASHED to discuss their favorite wrestling announcers, Raven's entry into ECW, memories of Brian Pillman, the origin of THE RAVEN EFFECT podcast, why Raven chose the DDT, what makes Jerry Lawler great and much more!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Paul and Gerard are back with a loaded show that kicks off by covering some major matches from GLEAT, ZERO1 and DDT. Then it's on to NOAH where Mr. Smack Daddy and Kenoh deliver the goods and the company feels like it's heading in a better direction. Over in All Japan, the company wraps up a strong Jr. Heavyweight Tag Team tournament and some title defences. Plus a look at the Champion Carnival blocks and schedule.Our Sponsors:* Support our sponsor BetterHelp: https://www.betterhelp.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Paul and Gerard are back with a loaded show that kicks off by covering some major matches from GLEAT, ZERO1 and DDT. Then it's on to NOAH where Mr. Smack Daddy and Kenoh deliver the goods and the company feels like it's heading in a better direction. Over in All Japan, the company wraps up a strong Jr. Heavyweight Tag Team tournament and some title defences. Plus a look at the Champion Carnival blocks and schedule.

It's another John & John episode! John Bivins is back as the two of them break down an outstanding end to the New Japan Cup, talking the final two quarterfinal matches from night 10, both semifinals from night 11, and then the entire final night including of course the tournament final itself. Lots of talk about NJPW's young generation really stepping up, Shota Umino maybe forcing people to take some Ls (including at least one John!) and more, plus a look ahead to what the rest of the year might look like. Then it's over to DDT to talk an equally outstanding Judgement show from Korakuen Hall, a very deep card that showed off their huge bounty of young talent. We also discuss the very sad news of Kazusada Higuchi's sudden retirement.Afterward we break down AJPW's Hachioji show from 3/20, a weird card featuring a Triple Crown title match and not a whole lot else. Finally, we wrap things up with some of the highlights from all four TJPW shows down in Texas, and then a full preview of next weekend's big Grand Princess show!John Bivins' Instagram: https://www.instagram.com/punkrock.darkroast/Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialOur Sponsors:* Support our sponsor BetterHelp: https://www.betterhelp.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Liver Boost from MSW Nutrition is designed to support phase 1 and phase 2 detoxification pathways — the exact processes your liver uses to metabolize and clear estrogen. During perimenopause, when hormone levels fluctuate and detox pathways can become sluggish, supporting liver function is foundational. Liver Boost helps your body process hormones more efficiently, which can ease bloating, mood swings, skin changes, and stubborn weight fluctuations discussed throughout this episode.

GIVE IT UP FOR THE NINTH WONDER OF THE WORLD...CHYNA!Joanie Laurer (1969-2016) was an American professional athlete, wrestler, fitness model and actor best known as Chyna. Wrestling with the WWF from 1997-2001, her brief stint in their ring and the spotlight pushed athletic entertainment and beauty standards to new heights and challenged the status quo. The Dipperz have nothin' but love for Chyna! Featuring: The Testicular Claw, the Low Blow, the DDT, Military Press Slam, the Handspring Back Elbow, the Clothesline, and the Powerbomb. BONUS: ONE MORE TESTICULAR CLAW!Support the Pod: www.patreon.com/dipperzEmail the Pod: dipperzpod@gmail.comInstagram: @dipperz_podcast

GIVE IT UP FOR THE NINTH WONDER OF THE WORLD...CHYNA!Joanie Laurer (1969-2016) was an American professional athlete, wrestler, fitness model and actor best known as Chyna. Wrestling with the WWF from 1997-2001, her brief stint in their ring and the spotlight pushed athletic entertainment and beauty standards to new heights and challenged the status quo. The Dipperz have nothin' but love for Chyna! Featuring: The Testicular Claw, the Low Blow, the DDT, Military Press Slam, the Handspring Back Elbow, the Clothesline, and the Powerbomb. BONUS: ONE MORE TESTICULAR CLAW!Support the Pod: www.patreon.com/dipperzEmail the Pod: dipperzpod@gmail.comInstagram: @dipperz_podcast

Lawn darts. Radium face cream. Cocaine in soda. Bloodletting. Leaded gasoline.History is full of confident ideas that seemed safe — until consequences caught up.Why do smart people, trusted experts, and entire generations embrace ideas that later look reckless?This episode explores historical medical mistakes, dangerous consumer products, industrial-era optimism, radioactive beauty treatments, early pharmaceuticals like heroin and lithium soda, and cultural norms that once felt completely responsible.They weren't foolish.They were informed — with the information they had.Bloodletting was science.Radium was modern.Lead solved engine knock.DDT worked brilliantly — at first.Progress often succeeds before it reveals its price.This isn't about mocking the past.It's about recognizing a pattern.

Following a quick pitstop over to DDT. We reviewed MARIGOLD's recent Korakuen Hall show.

Een nieuw #nerdland maandoverzicht! Met deze maand: Moltbook! Natte modder! Ruimtevlinders! Loodbenzine! Romeins bordspel! Muggensnuiten! RNA! Slurfvingers! En veel meer... Shownotes: https://podcast.nerdland.be/nerdland-maandoverzicht-maart-2026/ Gepresenteerd door Lieven Scheire met Jeroen Baert, Els Aerts, Kurt Beheydt en Peter Berx. Opname, montage en mastering door Els Aerts en Jens Paeyeneers. (00:00:00) Intro (00:01:27) AI‑bots op Moltbook blijken niet echt autonoom, mensen sturen mee (00:12:29) Mini‑RNA dat zichzelf kan kopiëren als stap richting leven (00:18:21) Oorsprong van complex leven en eukaryoten ontrafeld (00:23:55) Audiotest: modder, banaan en koperdraad klinken even goed (00:36:24) Tele‑operated zelfrijdende auto's in Antwerpse haven (00:37:37) SPACE (00:37:37) Rups wordt vlinder in gewichtloosheid (00:41:11) Astronaute Sophie Adenot aangekomen in ISS (00:47:35) rtemis II opnieuw uitgesteld, raket terug naar assembly‑gebouw (01:05:17) Romeins bordspel gereconstrueerd met AI (01:10:26) Radioactieve hybride zwijnen rond Fukushima (01:13:07) Dode muskietensnuit als onverwacht goede 3D‑printnozzle (01:16:21) SILICON VALLEY NEWS (01:16:31) Tesla shifts van auto's naar robots (01:19:09) Unitree toont groepsacrobatiek door robots (01:25:06) Blue Origin shifts van ruimtetoerisme naar maanlander (01:28:25) OpenAI bouwt een… smart speaker? (01:32:09) Nieuwe Claude Opus 4.6 met betere codeer‑ en redeneercapaciteiten (01:40:16) Bitcoincrash en vrees dat munt naar nul gaat (01:43:05) Instortende NFT‑markt als komisch fenomeen (01:44:25) Luchtvervuiling verstoort mierenkolonies en veroorzaakt doden (01:52:43) Verbod op loodbenzine blijkt extreem effectieve milieumaatregel (01:58:49) DDT teruggevonden in Braziliaanse zeevogels (02:04:19) Internet noemt keverslak via Ze Frank (02:07:09) Olifant kan chips pakken dankzij gevoelige snorharen aan slurfpunt (02:10:41) Gegevensopslag in glas die tienduizend jaar meegaat (02:14:50) Proba‑3 wint Astro Award dankzij nominatie Stijn Ilsen (02:17:25) Vervolg crotchgate op de Winterspelen (02:19:02) Aankondigingen (02:30:21) Sponsor VAIA

That's the Democrat way!! PLUS, Dr. Sina McCullough, author of the new book Hands Off My Food! How to Defend Your Food, Health and Freedom, tells Shaun how the manipulation of our food that has been making us sick for decades, discusses the dangers of DDT and how our milk has been poisoned. And Scott Presler, author of the upcoming book The Persistence: How Scott Presler Cleaned Up America's Cities, Seized the Voter Registration Movement from Democrats, and Helped to Elect Donald Trump, tells Shuan how he studied the stolen the 2020 election to help Trump win the 204 election and how he is working hard to help pass the SAVE America Act to ensure our elections are safe again. Help Scott out by calling 202-224-3121 to make your voice heard and ensure it passes!!See omnystudio.com/listener for privacy information.

Wrestling Omakase is back with another packed episode, and unfortunately a lot of these shows were #bad. But hey, our returning guest Eric aka Snazzy from the Joshi-ing Around podcast and the Social Suplex newsletter is never bad! John & Eric discuss an absolutely wretched Dragongate Uno Dos Tres show from Fukuoka, as they unfortunately turned in a supremely poor effort for one of their biggest shows of the year. Then it's over to AJPW for their 2/23 Ota Ward Gym show, which cleared the DG show but was still fairly middling, before they wrap up the men's portion of the episode with (thankfully!) a show that was actually good in DDT's 2/23 Korakuen, featuring a bonafide MOTYC!Then it's over to the world of joshi starting with two STARDOM shows from 2/20 (Saori's homecoming show) & 2/21 (from Osaka EDION 2)- mostly standard house show fare, but with a few unique touches. They also speculate on who might win the upcoming Cinderella Tournament, and Snazzy has quite the idea on what the Yokohama Arena main event could end up being. After that they review Marigold's 2/23 Korakeun show, which unfortunately took us back to the land of sucking. They wrap things up with two more smaller joshi promotions' recent shows, Sendai Girls' 2/15 Sendai Pit show and a very rare Ice Ribbon show review (their 2/23 Yokohama show). A real mixed bag of an episode here, but hey, if you wanna hear effusive praise for some stuff and absolute burials at the same time, this is sure the one for you!Joshi-ing Around podcast: https://redcircle.com/shows/1309343e-3781-4750-9209-4efbc9976ab6Social Suplex newsletter: https://www.socialsuplex.com/newsletter/Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialOur Sponsors:* Sign up and get 10% off at BetterHelp: https://www.betterhelp.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Laird Hamberlain is a lifelong sportsman. When asked about his favorite thing to hunt, he'll respond with "DDT" (deer, ducks & turkey). The longtime Safari Club International CEO joined me for a candid conversation about the work SCI is doing both domestically and internationally. Highlights from our discussion include: The joys of watching your kids [...]

Kris and David are back to discuss the week that was January 29-February 4, 2002. Topics of discussion include:The XWF trying to get a TV deal with various outlets.Brian Knobbs and Greg Valentine cozying up to the big money backers of the XWF to try to milk them.Andrew McManus' WWA PPV in Las Vegas has its onsale delayed due to promoter's license issues.More on the aftermath of Keiji Muto and friends leaving New Japan for All Japan and how NJPW is trying to navigate the situation.The IWGP Heavyweight Title tournament begins in Sapporo.News on Kaz Hayashi returning home to Japan and his future plans.A wild Diana Hart interview in the Globe & Mail.A crazy night in Tijuana featuring a near riot among the fans.The Russ Haas Memorial Show in Jersey All-Pro Wrestling.Jim Cornette and Scott Hudson join up as the new announcing team for Bert Prentice's USA Championship Wrestling at a interesting show in Nashville.Scott Hall already causing issues in the WWF locker room as the nWo's entrance is making people very nervous about the locker room morale.L.L. Cool J steps up to Booker T on Smackdown.Stephanie McMahon tells Triple that she is pregnant and wants to renew their wedding vows in Las Vegas.All of this and so so much more on a slam-packed episode of BTS!!!!Timestamps:0:00:00 Startups: XWF & WWA0:22:06 Eurasia: NJPW, NOAH, Zero-One, Kaz Hayashi, BJPW, DDT, FMW, Michinoku Pro, NMC, Osaka Pro, SPWC, Toryumon, Arsion, NEO Ladies, Jake the Snake/All_Star, & FWA1:06:54 Other North America: NHBW, Diana Hart, CMLL, IWRG, Monterrey, Tijurana, IWAPR, & WWC1:31:20 Classic Commercial Break1:33:58 Halftime2:14:57 Other USA: JAPW Russ Haas Memorial, Blue Meanie/3PW, NWA Tri-State/PWX, MarylandCW, WrestleForce America, NWA Wildside, TurnbuckleCW, IWAMS, USACW, Memphis, MidwestCW, CPW, XPW, Superstar Billy Graham, & Joanie Laurer3:01:14 WWFTo support the show and get access to exclusive rewards like special members-only monthly themed shows, go to our Patreon page at Patreon.com/BetweenTheSheets and become an ongoing Patron. Becoming a Between the Sheets Patron will also get you exclusive access to not only the monthly themed episode of Between the Sheets, but also access to our new mailbag segment, a Patron-only chat room on Slack, and anything else we do outside of the main shows!If you're looking for the best deal on a VPN service—short for Virtual Private Network, it helps you get around regional restrictions as well as browse the internet more securely—then Private Internet Access is what you've been looking for. Not only will using our link help support Between The Sheets, but you'll get a special discount, with prices as low as $1.98/month if you go with a 40 month subscription. With numerous great features and even a TV-specific Android app to make streaming easier, there is no better choice if you're looking to subscribe to WWE Network, AEW Plus, and other region-locked services.For the best in both current and classic indie wrestling streaming, make sure to check out IndependentWrestling.tv and use coupon code BTSPOD for a free 5 day trial! (You can also go directly to TinyURL.com/IWTVsheets to sign up that way.) If you convert to a paid subscriber, we get a kickback for referring you, allowing you to support both the show and the indie scene.To subscribe, you can find us on iTunes, Google Play, and just about every other podcast app's directory, or you can also paste Feeds.FeedBurner.com/BTSheets into your favorite podcast app using whatever “add feed manually” option it has.Support this podcast at — https://redcircle.com/between-the-sheets/donationsAdvertising Inquiries: https://redcircle.com/brands

It's been more than half a century since the publication of Silent Spring by the scientist and creative writer Rachel Carson. The seminal volume caught the attention of U.S. presidents, artists and musicians, spurring the environmental movement and leading to the eventual ban of the toxic pesticide DDT. Joining the Mongabay Newscast is environmental writer and director of the creative writing program at Middlebury College, Megan Mayhew Bergman. She unpacks the impact of Carson's work, which came under public attack from chemical companies seeking to discredit her, and how, eventually, the truth broke through. "We don't change our minds usually based on data. We change our minds based on emotion, but historically, it's been pretty taboo for scientists to include emotion in the way that they write. And I feel like Carson risked that here in a way that was really powerful." Please take a minute to let us know what you think of our podcast, here. Image: Megan Mayhew Bergman. Image by Cameron Russell. Environmental writing and authors mentioned in this conversation: Braiding Sweetgrass by Robin Wall Kimmerer Florida by Lauren Groff The Home Place by J. Drew Lanham Hope Is the Thing With Feathers by Christopher Cokinos How Strange a Season by Megan Mayhew Bergman Silent Spring by Rachel Carson Under a White Sky by Elizabeth Kolbert Vesper Flights by Helen Macdonald The Wild Flag by E.B. White Zora Neale Hurston Other works and authors mentioned: Ecology of a Cracker Childhood by Janisse Ray Men We Reaped by Jasmyn Ward A Small Place by Jamaica Kincaid Speak Memory by Vladimir Nabokov —- Timestamps (00:00) Changing hearts and minds (02:46) Rachel Carson's journey to Silent Spring (08:22) Controversy and impact (14:40) Room for a new voice (20:55) Bioaccumulation and what it means (24:07) "We don't change our minds based on data" (26:43) Recommended reads (35:21) The American South and environmental writing (39:57) Lessons for writers

Will the Make America Healthy Again (MAHA) succeed? If the regulatory story of DDT is a prime example of government regulation in action, then the answer is a resounding no.Original article: https://mises.org/mises-wire/political-economy-pesticides-how-subsidize-poison

Will the Make America Healthy Again (MAHA) succeed? If the regulatory story of DDT is a prime example of government regulation in action, then the answer is a resounding no.Original article: https://mises.org/mises-wire/political-economy-pesticides-how-subsidize-poison

The Duo de Twang album is a fun listen, but the shows were where the guys really let loose and silliness reigned. Soya and frequent Twang contributor Wylie Woods drop by to talk about their experience on the road with DDT, including a show that Josh attended which they described as one of the worst of the tour, lousy conditions at Jam Cuirse, and an unexpected success in Europe. The big question: Who drank the most beer? Find out in this episode!Get involvedInstagramFacebookEmailBurn your money 

Wrestling Omakase is finally back to its regularly scheduled programming, as we're once again going weekly from here on out following our part-time schedule earlier in January (due to a combo of Japan trip, post-Japan trip blues/jet lag and then work stuff). John is joined by returning guest Velkej Bracha to discuss NJPW's 1/19 & 1/20 Road to New Beginning Korakuens (feat. the end of EVIL, a classic tag match, and a hot unit feud), STARDOM's 1/21 Korakuen (feat. the Tokyo HATE Squad Showdown and more blissful Maki/Saori interactions) and Marigold's 1/24 Korakuen (feat. Mayu Iwatani's 15th anniversary, now without STARDOM IP). People needing to take Ls is a big overriding theme as you'll find out. Then John goes solo to discuss two more shows, DDT's 1/25 Korakuen (feat. unit movement and A Second Suzuki Incident Has Struck The Building) and GLEAT's 1/20 Shinjuku FACE show. Yes, this is a GLEAT podcast now, apparently. Who knew?Follow Wrestling Omakase on Twitter: http://twitter.com/wrestleomakaseFollow John on BlueSky: https://bsky.app/profile/justoneenby.bsky.socialOur Sponsors:* Check out our sponsor BetterHelp at https://www.betterhelp.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Kris and David are back as we discuss the week that was January 6-12, 2010. Topics of discussion include:The immediate aftermath of TNA going head-to-head with WWE on January 4th and the politics behind the scenes regarding pushing Spike TV to give TNA a live weekly Monday night time slot.Jeff Jarrett's role in TNA being up in the air again.TNA airing a replay of the January 4th show in it's normal slot, which featured a bunch of both expected and unexpected edits changing the presentation from the live broadcast.Brian Kendrick explaining why he was fired from WWE.Vince Russo being Vince Russo in an interview.Kenta Kobashi getting surgery as his days as an active wrestler are numbered.NOAH getting rid of some of their more tenured talent as the business is changing in Japan.News on the premiere of Wrestlicious and how this promotion came to be.Randy Orton "assaults" a fan at a restaurant…or does he?Ted “The Trailer” McNaylor gets his head shaved on Smackdown at the behest of CM Punk.Mike Tyson guest hosts Raw and actually technically is in the main event, teaming with Chris Jericho against DX, and you can guess what happened there.2010 being 16 years ago is damn crazy, and we had a lot of fun looking backm so we hope you have as much fun listening!Timestamps:0:00:00 TNA1:03:53 Int'l: AJPW, NJPW, NOAH, BJPW, DDT, Dragongate, JWP, Oz Academy, AAA, CMLL, IWRG, & IWAPR1:49:57 Classic Commercial Break1:53:39 Halftime2:29:58 Other USA: JAPW, ROH, ICP/JCW, Dragongate USA, & Wrestlelicious2:53:12 WWETo support the show and get access to exclusive rewards like special members-only monthly themed shows, go to our Patreon page at Patreon.com/BetweenTheSheets and become an ongoing Patron. Becoming a Between the Sheets Patron will also get you exclusive access to not only the monthly themed episode of Between the Sheets, but also access to our new mailbag segment, a Patron-only chat room on Slack, and anything else we do outside of the main shows!If you're looking for the best deal on a VPN service—short for Virtual Private Network, it helps you get around regional restrictions as well as browse the internet more securely—then Private Internet Access is what you've been looking for. Not only will using our link help support Between The Sheets, but you'll get a special discount, with prices as low as $1.98/month if you go with a 40 month subscription. With numerous great features and even a TV-specific Android app to make streaming easier, there is no better choice if you're looking to subscribe to WWE Network, AEW Plus, and other region-locked services.For the best in both current and classic indie wrestling streaming, make sure to check out IndependentWrestling.tv and use coupon code BTSPOD for a free 5 day trial! (You can also go directly to TinyURL.com/IWTVsheets to sign up that way.) If you convert to a paid subscriber, we get a kickback for referring you, allowing you to support both the show and the indie scene.To subscribe, you can find us on iTunes, Google Play, and just about every other podcast app's directory, or you can also paste Feeds.FeedBurner.com/BTSheets into your favorite podcast app using whatever “add feed manually” option it has.Support this podcast at — https://redcircle.com/between-the-sheets/donationsAdvertising Inquiries: https://redcircle.com/brands

Bruce Lord and Karen Peterson review NJPW's Wrestle Kingdom 20 in Tokyo Dome, featuring Hiroshi Tanahashi vs. Kazuchika Okada and the retirement of Tanahashi after a twenty-six-year career.The semi-main event of Konosuke Takeshita vs. Yota Tsuji in a double championship match for the IWGP Global Heavyweight Championship and IWGP World Heavyweight Championship.Highlighted topics including the impact of live domestic broadcasting on the company's biggest show on their annual calendar, utilizing various fandom paths to draw in new viewers, the imbalance of ring-time versus length of entrances, inclusion of STARDOM and DDT talents, the EVIL/Wolf group project debrief, the emotional closure of Tanahashi's career with the parade of old rivals in Jay White, Will Ospreay, Kenny Omega, Kota Ibushi, Katsuyori Shibata, and a returning Tetsuya Naito and cherished mentors in  Keiji Muto and Tatsumi Fujinami.  Access all of our NJPW reviews by becoming a member at http://postwrestlingcafe.com------NJPW Wrestle Kingdom 20January 4, 2026Tokyo DomeTokyoHiroshi Tanahashi's Retirement Match: Hiroshi Tanahashi vs. Kazuchika Okada - RecommendedIWGP World & IWGP Global Heavyweight Championship: Konosuke Takeshita (c) World vs. Yota Tsuji (c) Global - RecommendedAaron Wolf Debut/NEVER Openweight Championship: EVIL (c) vs. Aaron Wolf (Debut) - RecommendedIWGP Jr. Heavyweight Championship No. 1 Contender 4-Way: El Desperado, Kosei Fujita, Taiji Ishimori & SHOShingo Takagi, David Finlay, Gabe Kidd, Drilla Moloney & Hiromu Takahashi vs. Great O'Khan, Callum Newman, HENARE, Andrare El Idolo & Jake LeeIWGP & NJPW STRONG Women's Championship: Syuri (c) IWGP vs. Saya Kamitani (c) STRONG - RecommendedNEVER Openweight Six Man Tag Team Championships Tornado Rambo: TMDK (Hartley Jackson, Ryohei Oiwa & Zack Sabre Jr.) vs. Master Wato, Toru Yano & YOH (c)  vs. Bishamon (Hirooki Goto & YOSHI-HASHI) & Oleg Boltin  vs. BULLET CLUB War Dogs (Clark Connors, OSKAR & Yuto-Ice)  vs. House Of Torture (Ren Narita, SANADA & Yoshinobu Kanemaru)  vs. Kaisei Takechi, Shota Umino & Yuya Uemura  vs. Ryusuke Taguchi, Tiger Mask & Togi Makabe  vs. Team 150 (Satoshi Kojima, Taichi & Tomohiro Ishii) NJPW World TV Championship: El Phantasmo (c) vs. Chris BrookesYoung Lions Kick-Off: Shoma Kato & Tatsuya Matsumoto vs. Katsuya Murashima & Masatora Yasuda Bluesky: https://bsky.app/profile/postwrestling.comX: http://www.twitter.com/POSTwrestlingInstagram: http://www.instagram.com/POSTwrestlingFacebook: http://www.facebook.com/POSTwrestlingYouTube: http://www.youtube.com/POSTwrestlingSubscribe: https://postwrestling.com/subscribePatreon: http://postwrestlingcafe.comForum: https://forum.postwrestling.comDiscord: https://postwrestling.com/discordAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Researchers have identified 168 everyday chemicals, including pesticides, flame retardants, and plastic additives, that are toxic to beneficial gut bacteria and may disrupt essential body functions Certain banned or restricted substances, like hexachlorophene and DDT, were also shown to damage gut microbes and promote inflammation and metabolic dysfunction Pesticides such as glyphosate, chlorpyrifos, and atrazine alter gut microbial balance and reduce protective species, allowing harmful bacteria to thrive and weakening your immune defenses Gut bacteria exposed to pesticides not only change how they grow but also how they process nutrients, interfere with detox pathways, and trigger inflammation in the gut, liver, and other organs Practical solutions like choosing organic produce, eating probiotic and prebiotic foods, filtering drinking water, and avoiding plastic containers can help protect and restore gut health